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CSD susceptibility in FHM1 mutant mice is modulated by Cav2.1 gain of 





























Enhanced CSD susceptibility in FHM1 mutant mice. (A) Representative electrophysiological recordings showing increased frequency of slow 
(DC) potential shifts during repetitive CSDs in male and female homozygous R192Q or S218L mutants compared with WT mice evoked by topical 
KCl application (300 mM) for 30 minutes. The number of CSDs was substantially higher in FHM1 mutant strains compared with WT controls and 
in female mutants versus males. Calibration bars: vertical, 20 mV; horizontal, 10 minutes. (B) The impact of R192Q and S218L mutations, allele 
dosage, and sex on CSD frequency and propagation speed (upper and lower graphs, respectively). Higher CSD frequencies and propagation 
speeds were found in both FHM1 mutants, with values higher in S218L than in R192Q mutants and an allele dosage relation. CSD frequency was 
greater and propagation faster in females compared with males in both FHM1 mutant strains. No sex difference was found in WT mice. Covari-
ance analysis revealed that 82% of variation in CSD frequency and 93% of variation in CSD propagation speed were explained by the indepen-
dent variables mutation, genotype, and sex (see Methods). Numbers of mice per group are shown within the bars. HET, heterozygous; HOM, 
homozygous. Data are mean ± standard deviation. **P < 0.001, *P < 0.01 versus male in CSD frequency and propagation speed; †P < 0.001 
versus WT and homozygous mutant; ‡P < 0.001 versus WT and heterozygous mutant; §P < 0.001 versus corresponding R192Q genotype.
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FHM1 mutant mice develop severe and prolonged motor deficits after 





















































Electrophysiological measures of CSD and systemic physiological parameters in FHM1 mutant mice
Genotype/sex	 Gonadal	status	 Age	(mo)	 n	 	Duration	(s)	 Amplitude	(mV)	 MABP	 pH	 pCO2	 pO2
R192Q	strain	 	 	 	 1st	CSD	 All	CSDs	 All	CSDs
WT male Normal 4.3 ± 0.8 9 42 ± 10 23 ± 11 25 ± 5 81 ± 10 7.36 ± 0.1 38 ± 9 147 ± 19
WT female Normal 3.7 ± 0.9 9 40 ± 10 16 ± 6 28 ± 3 81 ± 6 7.35 ± 0.03 40 ± 4 133 ± 13
 Ovx 3.7 ± 0.6 10 40 ± 9 18 ± 5 27 ± 3 82 ± 7 7.35 ± 0.03 35 ± 4 139 ± 18
 Ovx + estrogen 3.3 ± 0.0 5 34 ± 6 17 ± 5 30 ± 1 68 ± 6 7.36 ± 0.05 33 ± 4 155 ± 23
 Aged 11.9 ± 1.5 7 26 ± 4 11 ± 3 25 ± 6 83 ± 8 7.38 ± 0.04 30 ± 3 141 ± 22
HET male Normal 5.2 ± 1.4 11 41 ± 9 19 ± 6 25 ± 7 81 ± 6 7.37 ± 0.06 33 ± 6 133 ± 14
HET female Normal 4.3 ± 1.3 13 39 ± 11 16 ± 6 24 ± 8 77 ± 6 7.34 ± 0.04 33 ± 6 124 ± 15
HOM male Normal 4.4 ± 0.8 13 38 ± 10 15 ± 4 24 ± 5 80 ± 6 7.36 ± 0.05 33 ± 6 127 ± 20
HOM female Normal 3.3 ± 0.4 6 35 ± 7 12 ± 2 30 ± 4 81 ± 4 7.35 ± 0.02 34 ± 2 126 ± 20
 Ovx 4.4 ± 0.9 12 31 ± 6 13 ± 2 28 ± 3 88 ± 4 7.34 ± 0.05 36 ± 9 135 ± 34
 Ovx + estrogen 6.1 ± 0.3 6 30 ± 2 14 ± 2 30 ± 1 79 ± 2 7.38 ± 0.03 31 ± 3 130 ± 22
 Aged 13.0 ± 2.7 7 29 ± 1 13 ± 2 26 ± 1 81 ± 7 7.35 ± 0.04 33 ± 4 153 ± 22
S218L	strain
WT male Normal 2.7 ± 0.5 6 34 ± 2 14 ± 4 25 ± 2 88 ± 15 7.41 ± 0.03 27 ± 4 148 ± 17
WT female Normal 2.9 ± 0.7 7 32 ± 7 14 ± 4 25 ± 3 96 ± 7 7.36 ± 0.05 31 ± 4 138 ± 20
HET male Normal 3.0 ± 0.0 6 29 ± 4 11 ± 2 25 ± 6 93 ± 5 7.41 ± 0.02 29 ± 3 140 ± 9
HET female Normal 2.6 ± 0.5 5 35 ± 6 11 ± 2 24 ± 2 95 ± 6 7.38 ± 0.01 30 ± 2 144 ± 7
HOM male Normal 2.7 ± 0.5 6 36 ± 3 12 ± 3 21 ± 5 86 ± 9 7.37 ± 0.03 32 ± 4 126 ± 24
HOM female Normal 2.6 ± 0.5 7 29 ± 5 10 ± 1 25 ± 4 90 ± 2 7.35 ± 0.03 31 ± 4 134 ± 21
Values are mean ± standard deviation. CSD duration was measured at half amplitude. Because the duration, but not the amplitude, gradually decreased 
upon repetitive SDs in all groups, both the duration of first CSD and the average of all CSDs are presented. Group differences are not statistically significant 
(1-way ANOVA). Estrogen: 0.075 mg/pellet 21-day release. Mean arterial blood pressure (MABP) and arterial partial pressure of oxygen (pO2) and carbon 
dioxide (pCO2) are expressed in mmHg, averaged over 1-hour recordings. n, number of mice; Ovx, ovariectomized; HET, heterozygous; HOM, homozygous.
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Gonadal hormone–mediated modulation of CSD susceptibility in 
female FHM1 mutant mice. The impact of ovariectomy and senes-
cence on CSD susceptibility in WT and homozygous R192Q mutant 
mice. Both ovariectomy (3–4 months of age; gray) and senescence 
(13 months of age; white) reduced CSD frequency (left panel) and 
propagation speed (right panel) in homozygous female R192Q to 
the level of male mutants (see Figure 1B). Ovariectomy (n = 5) and 
aging (n = 7) had similar effects in heterozygous female R192Q mice 
(data not shown). In WT mice, gonadectomy or senescence did not 
alter CSD susceptibility. Experiments were performed 3 weeks after 
ovariectomy. Numbers of mice for each group are shown within the 
bars. Ovx, ovariectomized. Data are mean ± standard deviation. 
*P < 0.001, #P < 0.01 versus WT; †P < 0.001 versus naive young 
female mice of the same genotype.
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Prolonged and severe neurological deficits after SD in FHM1 mutant mice. Time course of neurological deficits in WT and FHM1 mutant mice 
after a single SD (A) or 9 SDs over 1 hour (B), as assessed by wire grip score and latency as well as neurological score. (A) Impact of allelic 
mutations and allele dosage. In WT mice, deficits were mild and short-lasting in wire grip test and undetectable by neurological scoring (trian-
gles). FHM1 mutants developed severe and prolonged deficits (P < 0.01 versus WT). These deficits were markedly more severe and prolonged 
in homozygous S218L (black circles) than in homozygous R192Q mutants (gray circles; P < 0.01) or heterozygous S218L mutants (squares; 
P < 0.01 in wire grip test, P < 0.05 in neurological scoring). n = 13, 7, 6, and 3 WT, homozygous R192Q, heterozygous S218L, and homozygous 
S218L mutant mice, respectively. (B) Sex differences. In WT mice, deficits were mild and completely recovered within 45 minutes after 9 SDs. 
In contrast, R192Q mutant mice developed severe and prolonged deficits that lasted 80 minutes or more after 9 SDs (P < 0.01 versus WT). 
Importantly, female mutant mice (circles) were more severely affected than males (squares; P < 0.01). Deficits did not differ between WT males 
and females; therefore, data were pooled (triangles). n = 15, 6, and 7 WT, male R192Q, and female R192Q mutant mice, respectively. Error bars 
were omitted for clarity but were less than 25% of mean.
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The recovery of whisker pad stimulation–evoked cortical field potentials. (A) Representative tracings showing field potentials in a female WT 
(top), homozygous female R192Q mutant (middle), and heterozygous female S218L mutant mouse (bottom), evoked by electrical stimulation 
of the whisker pad (black triangles) and recorded from the whisker barrel field using extracellular glass micropipettes (400 μm depth, layer IV). 
Evoked potentials ranging from 2 to 4 mV in amplitude at baseline (column a) were abolished upon arrival of SD at the recording site (column b) 
and gradually recovered within less than 10 minutes (columns c–e), as shown in the time course graph in B. Calibration bars: vertical, 1 mV; 
horizontal, 20 ms. (B) The time course of recovery of somatosensory evoked field potentials (SSEP) after a single SD (time 0).The AUC for each 
evoked field potential (mV • ms) was expressed as percent of pre-SD baseline. The rate of recovery of cortical evoked field potentials did not 
differ among WT and FHM1 mutant mice. Recovery of peak amplitudes also did not differ among groups (data not shown). Numbers of mice are 
indicated in the graph. Male and female WT mice did not differ; therefore, pooled data are shown. Error bars were omitted for clarity.
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Preparation of targeting construct and 
generation of FHM1 mutant mice. Trans-





































Care and performed in accordance with the NIH Guide for the care and use of 
laboratory animals (NIH publication no. 85-23. Revised 1985).








Facilitated corticostriatal SD propagation in FHM1 mutant mice. (A) Representative extracellular DC 
potential shifts recorded simultaneously from cortex and striatum in female WT and homozygous 
R192Q and S218L mutant mice. SD was not observed to propagate into the striatum in any of the WT 
mice. A substantial proportion of CSDs propagated into the striatum in R192Q and to a greater extent 
in the S218L mutant. Calibration bars: vertical, 20 mV; horizontal, 10 minutes. (B) The frequency 
of SDs during continuous topical KCl application (300 mM) to the occipital cortex. CSD frequency 
(gray bars) was substantially higher in S218L and to a lesser extent in R192Q mutant mice than 
WT. They were higher in females compared with males and homozygous FHM1 mutants compared 
with heterozygotes (see Figure 1). CSDs readily propagated into striatum (black bars) in both FHM1 
mutant strains, but never in the WT. Striatal propagation was more frequent in S218L (lower graphs) 
compared with R192Q mutants (upper graphs) and in females (right) compared with males (left), with 
an allele dosage relation (see Table 2 for latencies between cortical and striatal SDs). Covariance 
analysis revealed that 83% of the variance of striatal SD frequency was explained by the indepen-
dent variables mutation, genotype, and sex (see Methods). n = 3–8 mice per group as shown within 
each bar. Data are mean ± standard deviation. *P < 0.01 versus male; †P < 0.001, §P < 0.05 versus 
heterozygous mutants; ‡P < 0.01 versus R192Q males.
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Corticostriatal propagation latency of SD
Strain	 Genotype	 Male	 Female
R192Q HET 3.7 ± 0.3 4.0 ± 0.6
 HOM 3.5 ± 0.5 1.5 ± 0.2A,B
S218L HET 3.3 ± 0.8 3.6 ± 0.5
 HOM 2.0 ± 0.6A,C 1.5 ± 0.3A
Values are mean ± standard deviation, expressed in minutes. AP < 0.01 
versus heterozygote; BP < 0.01 vs. male; CP < 0.01 versus R192Q. See 
Figure 5 for the number of mice in each group.
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